COMPANY PROFILE

Aspreva Pharmaceuticals Corp

Explore full profile

Emerging pharmaceutical company

Victoria, CanadaFounded 2001Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2007

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Aspreva Pharmaceuticals Corp

Aspreva is a global pharmaceuticals company specializing in the discovery, development, manufacturing, and marketing of therapies for iron deficiency, nephrology, and cardio-renal conditions. The company serves patients with severe and chronic diseases, aiming to improve their quality of life through innovative treatments. Aspreva operates in the healthcare market, focusing on both prescription and non-prescription medicines. Its business model revolves around partnering with other pharmaceutical companies and healthcare providers to deliver high-quality products and solutions. Revenue is generated through the sale of its diversified portfolio of pharmaceutical products, which includes both proprietary and partnered medicines. The company has a strong history dating back to 1872 and continues to drive scientific excellence in its field.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2001
Headquarters: Victoria, Canada
Open positions: None listed
Dealroom signal: 54.5/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Oct 2007	$915M	$915M	Galenica	—
IPOOther financing	Mar 2005	$0	—	Undisclosed	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Aspreva Pharmaceuticals Corp website traffic

Latest recorded traffic for Aspreva Pharmaceuticals Corp is 0 monthly website visits.

Latest monthly visits0

Monthly website visitsJan 2020–May 2020

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BBBexson BiomedicalKetamine and wearable device for post-operative pain	Santa Barbara, United States	Operational	7	$4.8M	$19M
ANAmygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction	Palo Alto, United States	Operational
BPBeckley PsytechClinical-stage biotechnology developing rapid-acting psychedelic medicines	Beckley and Stowood, United Kingdom	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
RBRosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology	Bristol, United Kingdom	Operational
EMEmpiricoHuge biological datasets, human genetics, and programmable biology to power novel target discovery and development	San Diego, United States	Operational
BRBraeburnBraeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction	Washington DC, United States	Operational
ATAddinex TechnologiesPrescription drug dispensing system to prevent misuse and addiction	Town of Riverhead, United States	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

SGSprout Group

Other known investors1 additional known investor

GAGalenica

Talent

Book a demo to see the people

Team profiled 2 named & role-tagged

Founders /100 quality score

Key operators 1 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇨🇦 Canada · Victoria HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aspreva Pharmaceuticals Corp on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aspreva Pharmaceuticals Corp’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.